Clinicopathological characteristics of mucinous breast cancer: a retrospective analysis of a 6-years study from national cancer center in Vietnam
Breast Cancer Research and Treatment · 2025
DOI: 10.1007/s10549-024-07529-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2025. Verfasst von Thi Huyen Phung und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Hanoi Medical University, Hanoi, Vietnam. Hauptthemen laut MEDLINE: Breast Neoplasms, Adenocarcinoma, Mucinous. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: To evaluate clinicopathological features in women with mucinous breast cancer (MBC), distinguishing between pure (PMC) and mixed (MMC) subtype. METHODS: A retrospective analysis of all 358 women with MBC treated at Vietnam National Cancer hospital from June 2015 to December 2020. PMC was defined by ≥ 90% mucinous components. RESULTS: We identified 358 women with MBC (245 PMC and 113 MMC) representing 2.7% of all 13,254 BC patients. The proportions of stage I, II, III and IV were 34.9%, 50.8%, 10.4% and 3.9% respectively. The rate of HER2 overexpression was 12%, and only 1.4% of patients was treated with anti-HER2. 193 patients (53.9%) had chemotherapy, including 55 patients (15.4%) treated in the neoadjuvant setting. Only 3 patients (5.5%) achieved pCR. PMC patients were older (54.4 ± 13.3 vs 51.1 ± 13.1 years), had lower Ki67 expression, lower incidence of nodal metastasis (N +) (p values < 0.05). At a median follow-up of 58 months, the 5-year overall survival rate of non-metastatic patients was 86.6%. Multivariate analysis showed N + to be the most significant prognostic factor (HR = 3.3; 95%CI 1.5-7.1), followed by T-stage (HR = 2.9; 95%CI 1.4-6.3), HER2 + (HR = 2.5; 95%CI 1.2-5.3) and MMC subtype (HR = 1.9; 95%CI 1.0-3.9). CONCLUSION: Poor prognostic factors of MBC include high T-stage, N-positivity, HER2 overexpression and MMC subtype. Given the low response rate to neoadjuvant CT, upfront surgery is appropriate for MBC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Hanoi Medical University, Hanoi, Vietnam.
- Department of Medical Oncology 6, Vietnam National Cancer Hospital, Hanoi, Vietnam.
- Department of Pathology, Vietnam National Cancer Hospital, Hanoi, Vietnam.
- Department of Oncology, Hanoi Medical University, Hanoi, Vietnam. hoanghoaihmu@gmail.com.
- Department of Medical Oncology 6, Vietnam National Cancer Hospital, Hanoi, Vietnam. hoanghoaihmu@gmail.com.
Zitieren
APA
Phung, T. H., Pham, T. T., Nguyen, H. T., Nguyen, D. T., Nguyen, T. L., & Hoang, T. H. (2025). Clinicopathological characteristics of mucinous breast cancer: a retrospective analysis of a 6-years study from national cancer center in Vietnam. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07529-x
Vancouver
Phung TH, Pham TT, Nguyen HT, Nguyen DT, Nguyen TL, Hoang TH. Clinicopathological characteristics of mucinous breast cancer: a retrospective analysis of a 6-years study from national cancer center in Vietnam. Breast Cancer Research and Treatment. 2025. doi:10.1007/s10549-024-07529-x
BibTeX
@article{Phung2025,
author = {Phung, Thi Huyen and Pham, Thanh Tung and Nguyen, Huu Thang and Nguyen, Dinh Thach and Nguyen, Thanh Long and Hoang, Thi Hoai},
title = {Clinicopathological characteristics of mucinous breast cancer: a retrospective analysis of a 6-years study from national cancer center in Vietnam},
journal = {Breast Cancer Research and Treatment},
year = {2025},
doi = {10.1007/s10549-024-07529-x}
}
EUVIMED